JACQUELINE RAMOS: Open Payments
NPI 1881239572 · LEHIGH ACRES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,616 in 79 payments from 17 companies in 2025. Trend: 2023 $1,508 · 2024 $1,800 · 2025 $1,616
Food & beverage: $1,616
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $340 |
| GlaxoSmithKline, LLC. | 11 | $239 |
| ABBVIE INC. | 10 | $198 |
| AstraZeneca Pharmaceuticals LP | 5 | $145 |
| Novartis Pharmaceuticals Corporation | 5 | $92 |
| Exact Sciences Corporation | 3 | $85 |
| Lilly USA, LLC | 4 | $83 |
| Axsome Therapeutics, Inc. | 4 | $80 |
| Abbott Laboratories | 3 | $66 |
| Esperion Therapeutics, Inc. | 3 | $57 |
Products named: TRELEGY ELLIPTA, Ozempic, VRAYLAR, AIRSUPRA, LEQVIO, JARDIANCE, Cologuard Collection Kit, Rybelsus.
Industry payments across FL — which companies pay providers there.
